Decorative spacer for background

APL-UW Home

University of Washington W Logo

Jobs
About
Campus Map
Contact
Privacy
YouTube
Facebook
Intranet

Yak-Nam Wang

Research Scientist Engineer - Principal

Email

ynwang@apl.washington.edu

Phone

206-616-6673

Education

B.S. Biomedical Materials Science & Engineering, Queen Mary & Westfield College, University of London, UK, 1996

Ph.D. Biomedical Materials, Queen Mary & Westfield College, University of London, UK, 2000

Videos

Mechanical Tissue Ablation with Focused Ultrasound

An experimental noninvasive surgery method uses nonlinear ultrasound pulses to liquefy tissue at remote target sites within a small focal region without damaging intervening tissues. A multi-institution, international team led by CIMU researchers is applying the method to the focal treatment of prostate tumors.

More Info

19 Mar 2020

Boiling histotripsy utilizes sequences of millisecond-duration HIFU pulses with high-amplitude shocks that form at the focus by nonlinear propagation effects. Due to strong attenuation of the ultrasound energy at the shocks, these nonlinear waves rapidly heat tissue and generate millimeter-sized boiling bubbles at the focus within each pulse. Then the further interaction of subsequent shocks with the vapor cavity causes tissue disintegration into subcellular debris through the acoustic atomization mechanism.

The method was proposed at APL-UW in collaboration with Moscow State University (Russia) and now is being evaluated for various clinical applications. It has particular promise because of its important clinical advantages: the treatment of tissue volumes can be accelerated while sparing adjacent structures and not injuring intervening tissues; it generates precisely controlled mechanical lesions with sharp margins; the method can be implemented in existing clinical systems; and it can be used with real-time ultrasound imaging for targeting, guidance, and evaluation of outcomes. In addition, compared to thermal ablation, BH may lead to faster resorption of the liquefied lesion contents.

Non-invasive Treatment of Abscesses with Ultrasound

Abscesses are walled-off collections of fluid and bacteria within the body. They are common complications of surgery, trauma, and systemic infections. Typical treatment is the surgical placement of a drainage catheter to drain the abscess fluid over several days. Dr. Keith Chan and researchers at APL-UW's Center for Industrial + Medical Ultrasound are exploring how to treat abscesses non-invasively, that is, from outside the body, with high-intensity focused ultrasound (HIFU). This experimental therapy could reduce pain, radiation exposure, antibiotic use, and costs for patients with abscesses. Therapeutic ultrasound could also treat abscesses too small or inaccessible for conventional drainage.

20 Jun 2016

Publications

2000-present and while at APL-UW

Transient tumor perfusion loss: Evaluating the spatial and temporal dynamics of blood flow changes induced by ultrasound cavitation treatment

Krolak, C., L. De Koninck, S. Gu, Y.-N. Wang, and M. Averkiou, "Transient tumor perfusion loss: Evaluating the spatial and temporal dynamics of blood flow changes induced by ultrasound cavitation treatment," Ultrasonics, 167, doi:10.1016/j.ultras.2026.108197, 2026.

More Info

1 Nov 2026

Ultrasound‑mediated microbubble cavitation can induce transient tumor perfusion loss (TTPL), yet the pressure‑dependent magnitude and short‑timescale recovery of this effect remains poorly defined. This study investigated how acoustic pressure governs both the extent and duration of TTPL following a single cavitation exposure. Subcutaneous hepatocellular carcinoma tumors (HEPG2 human cell line) in athymic nude mice (n = 15) received a 1‑second cavitation treatment at peak‑negative pressures of 1.4, 2.8, or 4.1 MPa. Due to the small f-number of the transducer employed, the estimated average peak negative pressures of these conditions within the tumor were 0.6, 1.1, and 1.7 MPa respectively. Tumor perfusion was evaluated using contrast‑enhanced ultrasound (CEUS) immediately (within 1 min), 5, 15, 30, and 60 min after treatment. Perfused area loss was quantified with a maximum intensity projection time‑area curve (MIP‑TAC) metric. Cavitation activity was assessed using passive cavitation detection (PCD), and histology evaluated acute tissue effects. Low acoustic pressure produced only partial perfusion loss with full recovery within 5 min. Moderate acoustic pressure induced substantial TTPL followed by near complete recovery by 15 min. High‑pressure treatment caused complete perfusion loss in all tumors, with initial recovery at 15 min but also with a subsequent decline over the hour. Elevated broadband energy recorded with PCD confirmed inertial cavitation in the moderate and high conditions. Histology revealed damage‑associated staining in 1/5 moderate‑pressure tumors and 3/5 high‑pressure tumors, consistent with pressure‑dependent mechanical injury, possibly contributing to the gradual decline in tumor perfusion observed after initial rebound in the high-pressure condition.

Ultrasound cavitation therapy: Inducing tumor drug delivery and blood flow changes with clinical ultrasound tools

Krolak, C., L. De Koninck, S. Gu, Y.-N. Wang, J.E. Powers, and M. Averkiou, "Ultrasound cavitation therapy: Inducing tumor drug delivery and blood flow changes with clinical ultrasound tools," J. Controlled Release, 393, doi:, 2026.

More Info

10 May 2026

Hepatocellular carcinoma (HCC), the fourth leading cause of cancer-related deaths, remains difficult to treat due to underlying liver disease, abnormal tumor vasculature, elevated interstitial fluid pressure (IFP), and immune suppression. We developed a theranostic approach using ultrasound cavitation with a clinical scanner and FDA-approved microbubbles to enhance vascular permeability and drug delivery in HCC. Acute experiments were performed in a subcutaneous HCC mouse model using a modified Philips EPIQ scanner and S5–1 phased-array probe under two conditions: moderate (1.6 MPa) and high (2.2 MPa) peak negative pressures. Contrast-enhanced ultrasound was acquired before, during, and after treatment, and vascular changes were quantified using a novel maximum intensity projection time area curve (MIP-TAC) analysis. Passive cavitation detection monitored microbubble activity. Doxorubicin extravasation, IFP (with a pressure catheter), and histology were assessed. Both ultrasound conditions induced transient tumor perfusion loss and reduced IFP without significant tissue damage or hemorrhage. The high-pressure treatment caused the greatest perfusion loss, whereas enhanced doxorubicin delivery occurred under moderate pressure. This result is likely due to excessive tumor perfusion loss in the high-pressure group, impeding further drug transport. These results demonstrate the feasibility of therapeutic cavitation with longer than previously evaluated acoustic pulses (1000 cycles) on a clinical scanner and clinically-approved microbubbles in HCC. Moderate-pressure cavitation maximized drug extravasation, underscoring the need to balance transient tumor perfusion loss with drug delivery. This clinically translatable strategy has potential to improve therapeutic outcomes in human HCC.

Facilitated clearance of small, asymptomatic renal stones with burst wave lithotripsy and ultrasonic propulsion

Harper, J.D., and 18 others including B. Dunmire, J. Thiel, Y.-N. Wang, S. Totten, J.C. Kucewicz, and M.R. Bailey, "Facilitated clearance of small, asymptomatic renal stones with burst wave lithotripsy and ultrasonic propulsion," J. Urol., 214, 41-47, doi:10.1097/JU.0000000000004533, 2025.

More Info

1 Jul 2025

We tested feasibility of burst wave lithotripsy (BWL) and ultrasonic propulsion to noninvasively fragment and expel small, asymptomatic renal stones in awake participants.

Adult patients suspected of having 2- to 7-mm stones were consented and screened for eligibility. BWL and ultrasonic propulsion were applied to up to 3 stones in 1 kidney of qualifying participants for a 30-minute total exposure. Participants completed a CT scan and the Wisconsin Stone Quality-of-Life (WISQOL) questionnaire within 90 days before and 120 days after the procedure. Participants were contacted weekly for 3 weeks after the procedure to assess adverse events (AEs). Outcomes included (1) no fragment > 2 mm, (2) unanticipated health care visits, (3) change in stone volume, (4) reported AEs, and (5) WISQOL score.

Forty-one participants were enrolled between April 2023 and October 2024. Twenty-one participants failed screening because no stones were seen, stones were too large or small, stone visibility was too deep or obstructed, or they declined to participate. Twenty participants with 31 stones received the research procedure with 7 undergoing a single repeat procedure. Twenty-two of 31 stones (71%) met the primary effectiveness outcome of no fragment > 2 mm, with 17 of 31 stones (55%) reported as stone free. Median stone volume reduction (IQR) was 100% (88%–100%). No participants returned unexpectedly for care related to the procedure. AEs were all Grade I by modified Clavien classification. WISQOL scores improved on 10 of 15 completed questionnaires.

Small, asymptomatic renal stones were effectively and safely removed in awake participants in a clinic setting.

More Publications

Inventions

Boiling histotripsy methods and systems for uniform volumetric ablation of an object by high-intensity focused ultrasound waves with shocks

An example method includes generating an acoustic ultrasound wave that is focused at a focal point. The method further includes sequentially directing the focal point upon distinct portions of an object to form respective shock waves at the distinct portions of the object. The method further includes, via the respective shock waves, causing the distinct portions of the object to boil and form respective vapor cavities. The method further includes causing substantially uniform ablation of a region of the object that comprises the distinct portions. The substantially uniform ablation is caused via interaction of the respective shock waves with the respective vapor cavities. An example ablation system and an example non-transitory computer-readable medium, both related to the example method, are also disclosed.

Patent Number: 12,157,018

Vera Khokhlova, Mike Bailey, Wayne Kreider, Oleg Sapozhnikov, Yak-Nam Wang

Patent

3 Dec 2024

High Intensity Focused Ultrasound Systems for Treating Tissue

Inventors: Y.-N. Wang, M.R. Bailey, T.D. Khokhlova (Seattle), W. Kreider, A.D. Maxwell, G.R. Schade (Seattle), and V.A. Khokhlova

Patent Number: 11,857,813

Yak-Nam Wang, Mike Bailey, Wayne Kreider, Adam Maxwell, Vera Khokhlova

Patent

2 Jan 2024

Histotripsy Treatment of Hematoma

A rapid, definitive intervention aiming at evacuation of the space-occupying hematoma would reduce pain, improve function, and avoid long term sequelae. Ultrasound is known to promote intravascular clot breakdown, as both a standalone procedure and used in conjunction with thrombolytic drugs and/or microbubbles. In-vitro and in-vivo studies have been conducted over the years, and acoustic cavitation is widely accepted as the dominant mechanism for mechanical disruption of the clot integrity and partial or complete recanalization of the vessel. Recently, a technique termed histotripsy that employs high-intensity focused ultrasound (HIFU) has been demonstrated to dissolve large in vitro and in vivo vascular clots without thrombolytic drugs within 1.5-5 minutes into debris 98% of which were smaller than 5 microns. However, this approach cannot be applied to the large extravascular hematomas due to their large volume (20-50 cc's) compared to intravascular clots, which necessitates much higher thrombolysis rates to complete the treatment within clinically relevant times (.about.15-20 minutes).

Patent Number: 10,702,719

Tatiana Khokhlova, Tom Matula, Wayne Monsky, Yak-Nam Wang

Patent

7 Jul 2020

More Inventions

Acoustics Air-Sea Interaction & Remote Sensing Center for Industrial & Medical Ultrasound Electronic & Photonic Systems Environmental & Information Systems Ocean Engineering Ocean Physics Polar Science Center
Close

 

Close